Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84.

PMID:
16878045
2.

Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.

Kenya S, Chida N, Symes S, Shor-Posner G.

HIV Med. 2011 Oct;12(9):525-34. doi: 10.1111/j.1468-1293.2011.00921.x. Epub 2011 Apr 24. Review.

3.

The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Giordano TP, Suarez-Almazor ME, Grimes RM.

Curr HIV/AIDS Rep. 2005 Nov;2(4):177-83. Review.

PMID:
16343375
4.

Adherence to antiretrovirals in HIV disease.

Cinti SK.

AIDS Read. 2000 Dec;10(12):709-17. Review.

PMID:
11189742
5.

Measuring adherence to highly active antiretroviral therapy: implications for research and practice.

Kerr T, Walsh J, Lloyd-Smith E, Wood E.

Curr HIV/AIDS Rep. 2005 Nov;2(4):200-5. Review.

PMID:
16343379
6.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR.

JAMA. 2006 Aug 9;296(6):679-90. Review.

PMID:
16896111
7.

The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.

Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H.

Bull World Health Organ. 2004 Jun;82(6):462-9. Review. Erratum in: Bull World Health Organ. 2004 Aug;82(8):571.

9.

Neurocognitive aspects of medication adherence in HIV infection.

Selnes OA.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S132-5. Review.

PMID:
12562036
10.

Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Fox MP, Rosen S.

Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15. doi: 10.1111/j.1365-3156.2010.02508.x. Review.

11.
12.

Adherence in clinical trials and in clinical practice.

Walsh JC.

Antivir Ther. 1999;4 Suppl 3:49-54. Review.

PMID:
16021871
13.
14.

Optimal delivery of HAART during hospitalization.

Colebunders R, Schueremans L, Robertson-Bell D, Alvarez-Vald├ęs VG, De Schacht C, Mispelters J, Gillisjans F, De Lee G, Ostyn B.

AIDS Read. 2004 Apr;14(4):198-200. Review. No abstract available.

PMID:
15116702
15.

Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North America.

Binagwaho A, Nutt CT, Mugwaneza P, Wagner CM, Nsanzimana S.

PLoS Med. 2014 Sep 9;11(9):e1001719. doi: 10.1371/journal.pmed.1001719. eCollection 2014 Sep. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk